SCHEMBL19682584

SCHEMBL19682584

C[C@H](c1cccc2c1Cc1ccccc1-2)[C@H](N)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
HTR2B P41595 3/20 0.43
HTR7 P34969 2/20 0.43
PNMT P11086 1/20 0.41
SLC1A2 P43004 3/20 0.38
SLC1A3 P43003 2/20 0.38
SLC1A1 P43005 2/20 0.38
SRD5A2 P31213 1/20 0.37
ALOX5 P09917 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
RRM1 P23921 1/20 0.36
RRM2B Q7LG56 1/20 0.36
HTR2C P28335 2/20 0.35
DRD2 P14416 2/20 0.35
ADRA1D P25100 1/20 0.35
HTR2A P28223 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20889365 1.00 NPC1 (0.46) NPC1RAB9AHTR2BHTR7PNMT
SCHEMBL21443923 0.86 NPC1 (0.48) NPC1RAB9AHTR2BHTR7PNMT
SCHEMBL20889261 0.83 HTR2B (0.43) NPC1RAB9AHTR2BSLC1A2SLC1A3
SCHEMBL19682585 0.83 HTR2B (0.43) NPC1RAB9AHTR2BSLC1A2SLC1A3
SCHEMBL8197052 0.82 HTR7 (0.47) NPC1RAB9AHTR2BHTR7PNMT
SCHEMBL9420910 0.82 NPC1 (0.50) NPC1RAB9AHTR2BHTR7PNMT
SCHEMBL21046174 0.82 HTR2B (0.49) NPC1RAB9AHTR2BHTR7PNMT
SCHEMBL19682751 0.77 RXRA (0.40) CHRM2CHRM1RRM1RRM2B
SCHEMBL19682589 0.77 BCL2L1 (0.41) CHRM2CHRM1RRM1RRM2B
SCHEMBL20889215 0.77 BCL2L1 (0.41) CHRM2CHRM1RRM1RRM2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10889555-B2 Sulfonamide compound or salt thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-01-12 US disclosed
US-20200405697-A1 Antitumor Agent TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-12-31 US disclosed
US-20200399235-A1 Sulfonamide Compound or Salt Thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-12-24 US disclosed
US-20200157066-A1 Sulfonamide Compound or Salt Thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-05-21 US disclosed
EP-3466934-A1 SULFONAMIDE COMPOUND OR SALT THEREOF Taiho Pharmaceutical Co., Ltd. (JP) 2019-04-10 EP disclosed
WO-2017209155-A1 SULFONAMIDE COMPOUND OR SALT THEREOF 大鵬薬品工業株式会社 2017-12-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200399235-A1 Sulfonamide Compound or Salt Thereof RNASEH1, SNRPA1, RRM2 NPC1 2770/4885RAB9A 3782/4885HTR2B 2889/4885
US-20200157066-A1 Sulfonamide Compound or Salt Thereof RNASEH1, SNRPA1, RRM2 NPC1 2770/4885RAB9A 3782/4885HTR2B 2889/4885
US-10889555-B2 Sulfonamide compound or salt thereof RNASEH1, SNRPA1, RRM2 NPC1 2770/4885RAB9A 3782/4885HTR2B 2889/4885
US-20200405697-A1 Antitumor Agent HNRNPR, RRM2, RRM2B NPC1 2311/4885RAB9A 2987/4885HTR2B 3462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.